Dang Wei

Dang Wei

Auto-generated profile, based on publicly available information

Dang Wei

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2024 in European Heart Journal
Verified
Journal Article
Open access
PDF file
DLDonghao Lu
Donghao Lu
UVUnnur A Valdimarsdóttir
Unnur A Valdimarsdóttir
DWDang Wei
Dang Wei
YCYufeng Chen
Yufeng Chen
OAOle A Andreassen
Ole A Andreassen
EBEmma Bränn
Emma Bränn
Increasing evidence suggests that some reproductive factors/hazards are associated with a future risk of cardiovascular disease (CVD) in women. While major (non-perinatal) depression has consistently been associated with CVD, the long-term risk of CVD after perinatal depression (PND) is largely unknown. A nationwide population-based matched cohort study involving 55 539 women diagnosed with PND during 2001–14 in Sweden and 545 567 unaffected women individually matched on age and year of conception/delivery was conducted. All women were followed up to 2020. Perinatal depression and CVD were identified from Swedish national health registers. Using multivariable Cox models, hazard ratios (HR) of any and type-specific CVD according to PND were estimated. The mean age at the PND diagnosis was 30.8 [standard deviation (SD) 5.6] years. During the follow-up of up to 20 years (mean 10.4, SD 3.6), 3533 (6.4%) women with PND (expected number 2077) and 20 202 (3.7%) unaffected women developed CVD. Compared with matched unaffected women, women with PND had a 36% higher risk of developing CVD [adjusted HR = 1.36, 95% confidence interval (CI): 1.31–1.42], while compared with their sisters, women with PND had a 20% higher risk of CVD (adjusted HR = 1.20, 95% CI 1.07–1.34). The results were most pronounced in women without a history of psychiatric disorder (P for interaction < .001). The association was observed for all CVD subtypes, with the highest HR in the case of hypertensive disease (HR = 1.50, 95% CI: 1.41–1.60), ischaemic heart disease (HR = 1.37, 95% CI: 1.13–1.65), and heart failure (HR 1.36, 95% CI: 1.06–1.74). Women with PND are at higher risk of CVD in middle adulthood. Reproductive history, including PND, should be considered in CVD risk assessments of women. Overview of the study design and the main results: association between perinatal depression (PND) and any subsequent cardiovascular disease (CVD) as well as separate analyses for antepartum and postpartum depression. CI, confidence interval; HR, hazard ratio; IR, incidence rate per 1000 person-years; N, obs., number of CVD events.

7 April 2016 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
PDF file
DWD Wei
D Wei
YCY Chen
Y Chen
CWC Wu
C Wu
QWQ Wu
Q Wu
LYL Yao
L Yao
KYKh Yang
Kh Yang
Background: Paroxetine is the first non‐hormone therapy for vasomotor symptoms (VMS) approved based on the results of two phase 3, randomised, placebo‐controlled trials by the Food and Drug Administration (FDA) in 2013.Objective: To confirm the effect and safety of paroxetine for vasomotor symptoms (VMS).Search strategy: MEDLINE, EMBASE, PsycINFO, CENTRAL, WHO International Clinical Trials Registry Platform (ICTRP) and four Chinese databases was searched from the date of their inception to 7 June 2014.Selection criteria: We included RCTs on the effect of paroxetine compared with placebo or no treatment for perimenopausal and postmenopausal women who experienced moderate‐to‐severe vasomotor symptoms.Data collection and analysis: Two reviewers screened records and extracted the information independently. The included studies were appraised by two independent reviewers using the Cochrane risk of bias tool. We synthesised the data in random‐effects models and rated the quality of evidence using GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach.Main results: Five articles with six RCTs (1571 participants) were included. Paroxetine significantly reduced the frequency of hot flushes by 8.86 per week (95% confidence interval (CI) 5.69–12.04, P < 0.00001, I2 = 83%) at week 4 and 7.36 per week (95% CI, 4.25–10.46, P < 0.00001, I2 = 62%) at week 12. The quality of the evidence on the effect of paroxetine for VMS was moderate.Conclusions: There was moderate quality of evidence supporting the effectiveness of paroxetine for vasomotor symptoms; however, it causes nausea and dizziness.Tweetable Review finds paroxetine effective for menopausal symptoms with some side effects: evidence strength moderate.

30 January 2021 in European Heart Journal
Verified
Journal Article
Open access
PDF file
DWDang Wei
Dang Wei
TOTristan Olofsson
Tristan Olofsson
HCHua Chen
Hua Chen
IJImre Janszky
Imre Janszky
FFFang Fang
Fang Fang
KLKrisztina D László
Krisztina D László
The role of psychological stress in the aetiology of atrial fibrillation (AF) is unclear. The death of a child is one of the most severe sources of stress. We aimed to investigate whether the death of a child is associated with an increased risk of AF. We studied parents with children born during 1973–2014 included the Swedish Medical Birth Register (n = 3 924 237). Information on death of a child, AF and socioeconomic, lifestyle and health-related covariates was obtained through linkage to nationwide population and health registers. We examined the link between death of a child and AF risk using Poisson regression. Parents who lost a child had a 15% higher risk of AF than unexposed parents [incidence rate ratio (IRR) and 95% confidence intervals (CI): 1.15 (1.10–1.20)]. An increased risk of AF was observed not only if the child died due to cardiovascular causes [IRR (95% CI): 1.35 (1.17–1.56)], but also in case of deaths due to other natural [IRR (95% CI): 1.15 (1.09–1.21)] or unnatural [IRR (95% CI): 1.10 (1.02–1.19)] causes. The risk of AF was highest in the 1st week after the loss [IRR (95% CI): 2.87 (1.44–5.75)] and remained 10–40% elevated on the long term. Death of a child was associated with a modestly increased risk of AF. Our finding that an increased risk was observed also after loss of a child due to unnatural deaths suggests that stress-related mechanisms may also be implicated in the development of AF.

29 September 2021 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
DWDang Wei
Dang Wei
IJImre Janszky
Imre Janszky
FFFang Fang
Fang Fang
HCHua Chen
Hua Chen
RLRickard Ljung
Rickard Ljung
KLKrisztina D. László
Krisztina D. László
Background: The death of a child is an extreme life event with potentially long-term health consequences. Knowledge about its association with ischemic heart diseases (IHDs) and acute myocardial infarction (AMI), however, is very limited. We investigated whether the death of an offspring is associated with the risk of IHD and AMI. Methods and findings: We studied parents of live-born children recorded in the Danish (1973 to 2016) and the Swedish (1973 to 2014) Medical Birth Registers (n = 6,711,952; mean age at baseline 31 years, 53% women). We retrieved information on exposure, outcomes, and covariates by linking individual-level information from several nationwide registers. We analyzed the abovementioned associations using Poisson regression. A total of 126,522 (1.9%) parents lost at least 1 child during the study period. Bereaved parents had a higher risk of IHD and AMI than the nonbereaved [incidence rate ratios (IRRs) (95% confidence intervals (CIs)): 1.20 (1.18 to 1.23), P < 0.001 and 1.21 (1.17 to 1.25), P < 0.001, respectively]. The association was present not only in case of losses due to CVD or other natural causes, but also in case of unnatural deaths. The AMI risk was highest in the first week after the loss [IRR (95% CI): 3.67 (2.08 to 6.46), P < 0.001], but a 20% to 40% increased risk was observed throughout the whole follow-up period. Study limitations include the possibility of residual confounding by socioeconomic, lifestyle, or health-related factors and the potentially limited generalizability of our findings outside Scandinavia. Conclusions: The death of an offspring was associated with an increased risk of IHD and AMI. The finding that the association was present also in case of losses due to unnatural causes, which are less likely to be confounded by cardiovascular risk factors clustering in families, suggests that stress-related mechanisms may also contribute to the observed associations.

24 October 2021 in European Journal of Heart Failure
Verified
Journal Article
Open access
PDF file
DWDang Wei
Dang Wei
JLJiong Li
Jiong Li
IJImre Janszky
Imre Janszky
HCHua Chen
Hua Chen
FFFang Fang
Fang Fang
KLKrisztina D. László
Krisztina D. László
Aims: We aimed to investigate whether the death of a child, one of the most severe stressors, is associated with the risk of heart failure (HF). Methods and results: We conducted a population‐based cohort study involving parents of live‐born children recorded in the Danish and Swedish Medical Birth Registers during 1973–2016 and 1973–2014, respectively ( n = 6 717 349). We retrieved information on child death, HF diagnosis and sociodemographic characteristics of the parents from several nationwide registries. We performed Poisson regression models to estimate incidence rate ratios (IRR) and 95% confidence intervals (CI) for HF in relation to bereavement. A total of 129 829 (1.9%) parents lost at least one child during the follow‐up. Bereaved parents had a 35% higher risk of HF than the non‐bereaved (IRR 1.35, 95% CI 1.29–1.41; p < 0.001). The increased HF risk was observed not only when the child died due to cardiovascular or other natural causes, but also when the loss was due to unnatural causes. The association tended to be U‐shaped when we categorized the exposed parents by the number of remaining live children at loss or by the age of the deceased child. Conclusion: We found that the death of a child was associated with an increased risk of HF. The finding that not only cardiovascular and other natural deaths, but also unnatural deaths were associated with HF suggests that stress‐related mechanisms may contribute to the development of HF.

5 February 2025 in EBioMedicine
Verified
Journal Article
Open access
DWDang Wei
Dang Wei
AFAnna Freydenzon
Anna Freydenzon
OGOctave Guinebretiere
Octave Guinebretiere
KZKarim Zaidi
Karim Zaidi
FYFen Yang
Fen Yang
ECEvans Cheruiyot
Evans Cheruiyot
Many studies have investigated early predictors for Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). However, evidence is sparse regarding specific and common predictors for these diseases. We aimed to identify medication use, health conditions, and blood biomarkers that might be associated with the risk of AD, PD, and ALS ten years later. We conducted population-based nested case-control studies of AD, PD, and ALS using electronic medical records in Europe (France, the UK, and Sweden) and Australia. We retrieved data on medication use, diagnosed health conditions, and measured blood biomarkers from electronic medical records or biomedical cohorts. Conditional logistic regression models and meta-analysis were applied to assess the associations between these factors and the risk of receiving a diagnosis of AD, PD, or ALS. We included a total of 149,642 AD cases (mean age: 79.1-81.2 years), 252,696 PD cases (73.2-75.9 years), and 27,533 ALS cases (64.4-69.6 years). The prescription of psychoanaleptics and nasal preparations was consistently associated with an increased risk of AD, PD, and ALS 5-10 years later. Constipation and use of related medications were associated with an increased risk of AD and PD, while diabetes and use of antidiabetics were associated with a reduced risk of ALS. A higher level of triglycerides was associated with a lower risk of AD, whereas a higher level of Apolipoprotein B was associated with a lower risk of PD, 5-10 years later. Psychoanaleptics and nasal preparations may serve as common predictors for diagnosis of AD, PD, and ALS 5-10 years later. Conversely, the increased prevalence of constipation is specific to AD and PD, while the decreased prevalence of diabetes and use of antidiabetics is specific to ALS. EU Joint Programme-Neurodegenerative Disease Research.